These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2141778)

  • 1. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Yao JD; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):827-30. PubMed ID: 2141778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B; Leclercq R; Arthur M; Duval J; Carbon C
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM; Thauvin-Eliopoulos C; Moellering RC
    Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Hindes RG; Willey SH; Eliopoulos GM; Rice LB; Eliopoulos CT; Murray BE; Moellering RC
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1019-22. PubMed ID: 2506803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Kitzis MD; Gutmann L; Cremieux AC; Maziere B; Vallois JM; Saleh-Mghir A; Lemeland JF; Carbon C
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2611-6. PubMed ID: 1336339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS; Pitsakis PG; Zausner A; Livornese LL; Osborne AJ; Johnson CC; Levison ME
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2069-73. PubMed ID: 8257125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M; Perichon B; Lefort A; Carbon C; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.
    Entenza JM; Calandra T; Moosmann Y; Malinverni R; Glauser MP
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1256-62. PubMed ID: 1416824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
    Sullam PM; Täuber MG; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
    Ingerman M; Pitsakis PG; Rosenberg A; Hessen MT; Abrutyn E; Murray BE; Levison ME
    J Infect Dis; 1987 Jun; 155(6):1226-32. PubMed ID: 3106510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis.
    Nicolau DP; Marangos MN; Nightingale CH; Patel KB; Cooper BW; Quintiliani R; Courvalin P; Quintiliani R
    Antimicrob Agents Chemother; 1996 Jan; 40(1):55-60. PubMed ID: 8787879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.
    Lefort A; Baptista M; Fantin B; Depardieu F; Arthur M; Carbon C; Courvalin P
    Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Pestel M; Kitzis MD; Lemeland JF; Humbert G; Gutmann L
    J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
    McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis.
    Aslangul E; Baptista M; Fantin B; Depardieu F; Arthur M; Courvalin P; Carbon C
    J Infect Dis; 1997 Mar; 175(3):598-605. PubMed ID: 9041331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.